Insulin glargine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Insulin glargine and local guidelines before prescribing.

Long-acting insulin analogue

Mechanism

Long-acting basal insulin analogue forming microprecipitates at injection site.

Uses

Basal insulin in type 1 and type 2 diabetes.

Dosing

Side effects

Hypoglycaemia, weight gain, injection-site reactions.

Interactions

Beta-blockers mask hypoglycaemia; corticosteroids raise glucose.

Contraindications and cautions

Hypoglycaemia

Monitoring

Glucose, HbA1c

Pregnancy and breastfeeding

Safe

Renal and hepatic impairment

Requirements fall in renal impairment

Overdose and reversal

Prolonged glucose infusion may be needed

Special advice

Never stop basal insulin in type 1 diabetes during illness; different strengths exist; rotate injection sites.

Where it is discussed in the book